LifeArc Ventures
Investor profile
Government / publicVenture capital
LifeArc Ventures has backed 7 European tech companies across 8 funding rounds between 2021 and 2026, joining rounds totalling €275M. Most active in Healthtech. Data as of Nov 2026.
Also recorded as: LifeArc
Deals
8
distinct rounds
Companies
7
backed
Active span
2021–2026
6 yrs
Total round €
€275M
sum of rounds joined
Deals by year
distinct rounds / yearLifeArc Ventures — deals by year — interactive chart.
Data table
| LifeArc Ventures — deals by year | |
|---|---|
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Top sectors
by dealsLifeArc Ventures — top sectors — interactive chart.
Data table
| LifeArc Ventures — top sectors | |
|---|---|
| Healthtech | 8 |
Stages
by dealsLifeArc Ventures — stages — interactive chart.
Data table
| LifeArc Ventures — stages | |
|---|---|
| Series A | 3 |
| Other | 2 |
| Series B | 2 |
| Seed | 1 |
Countries
by dealsLifeArc Ventures — countries — interactive chart.
Data table
| LifeArc Ventures — countries | |
|---|---|
| UK | 5 |
| Germany | 1 |
| Ireland | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- BGF3
- Monograph Capital2
- 5AM Ventures1
- Agent Capital1
- Ananda Impact Ventures1
- Andera Partners1
- Bristol Myers Squibb1
- British Patient Capital1
- Cambridge Angels1
- Carma Fund1
- Catalio1
- Clarendon Fund Managers Limited1
- Crista Galli Ventures1
- Dementia Discovery Fund1
- Downing Ventures1
- Eka Ventures1
- Eli lilly and company1
- EQT Life Sciences1
- Fountain Healthcare Partners1
- General Catalyst1
- GIMV1
- IQ Capital1
- LBBW Venture Capital GmbH1
- Longwall Ventures1
- MegaRobo Technologies1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| GlycoEra | Switzerland | 1 | €114M |
| Maxion Therapeutics | UK | 2 | €81M |
| Exciva | Germany | 1 | €51M |
| Closed Loop Medicine | UK | 1 | €15M |
| Cumulus Neuroscience | Ireland | 1 | €6.9M |
| Oxcan | UK | 1 | €3.5M |
| Surgery Hero | UK | 1 | €2.9M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| GlycoEra | Series B | €114M | 2025-05 |
| Maxion Therapeutics | Series A | €66M | 2025-03 |
| Exciva | Series B | €51M | 2026-01 |
| Closed Loop Medicine | Series A | €15M | 2021-11 |
| Maxion Therapeutics | Series A | €15M | 2023-02 |
| Cumulus Neuroscience | Other | €6.9M | 2021-05 |
| Oxcan | Other | €3.5M | 2023-01 |
| Surgery Hero | Seed | €2.9M | 2022-11 |